Literature DB >> 24865430

Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis.

Jessilyn Dunn, Haiwei Qiu, Soyeon Kim, Daudi Jjingo, Ryan Hoffman, Chan Woo Kim, Inhwan Jang, Dong Ju Son, Daniel Kim, Chenyi Pan, Yuhong Fan, I King Jordan, Hanjoong Jo.   

Abstract

In atherosclerosis, plaques preferentially develop in arterial regions of disturbed blood flow (d-flow), which alters endothelial gene expression and function. Here, we determined that d-flow regulates genome-wide DNA methylation patterns in a DNA methyltransferase-dependent (DNMT-dependent) manner. Induction of d-flow by partial carotid ligation surgery in a murine model induced DNMT1 in arterial endothelium. In cultured endothelial cells, DNMT1 was enhanced by oscillatory shear stress (OS), and reduction of DNMT with either the inhibitor 5-aza-2'-deoxycytidine (5Aza) or siRNA markedly reduced OS-induced endothelial inflammation. Moreover, administration of 5Aza reduced lesion formation in 2 mouse models of atherosclerosis. Using both reduced representation bisulfite sequencing (RRBS) and microarray, we determined that d-flow in the carotid artery resulted in hypermethylation within the promoters of 11 mechanosensitive genes and that 5Aza treatment restored normal methylation patterns. Of the identified genes, HoxA5 and Klf3 encode transcription factors that contain cAMP response elements, suggesting that the methylation status of these loci could serve as a mechanosensitive master switch in gene expression. Together, our results demonstrate that d-flow controls epigenomic DNA methylation patterns in a DNMT-dependent manner, which in turn alters endothelial gene expression and induces atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24865430      PMCID: PMC4071393          DOI: 10.1172/JCI74792

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  74 in total

1.  Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Jong-Gil Park; Ji-Young Yoo; Se-Jin Jeong; Jae-Hoon Choi; Mi-Ran Lee; Mi-Ni Lee; Jeong Hwa Lee; Hyoung Chin Kim; Hanjoong Jo; Dae-Yeul Yu; Sang Won Kang; Sue Goo Rhee; Mun-Han Lee; Goo Taeg Oh
Journal:  Circ Res       Date:  2011-08-11       Impact factor: 17.367

2.  A role for Hox A5 in regulating angiogenesis and vascular patterning.

Authors:  Kim Rhoads; Gemma Arderiu; Aubri Charboneau; Scott L Hansen; William Hoffman; Nancy Boudreau
Journal:  Lymphat Res Biol       Date:  2005       Impact factor: 2.589

3.  Human HOXA5 homeodomain enhances protein transduction and its application to vascular inflammation.

Authors:  Ji Young Lee; Kyoung Sook Park; Eun Jung Cho; Hee Kyoung Joo; Sang Ki Lee; Sang Do Lee; Jin Bong Park; Seok Jong Chang; Byeong Hwa Jeon
Journal:  Biochem Biophys Res Commun       Date:  2011-05-30       Impact factor: 3.575

4.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

5.  Genetic analyses of DNA methyltransferase genes in mouse model system.

Authors:  Masaki Okano; En Li
Journal:  J Nutr       Date:  2002-08       Impact factor: 4.798

6.  Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues.

Authors:  Xinmin Zhang; Duncan T Odom; Seung-Hoi Koo; Michael D Conkright; Gianluca Canettieri; Jennifer Best; Huaming Chen; Richard Jenner; Elizabeth Herbolsheimer; Elizabeth Jacobsen; Shilpa Kadam; Joseph R Ecker; Beverly Emerson; John B Hogenesch; Terry Unterman; Richard A Young; Marc Montminy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

7.  DNA hypomethylation and methyltransferase expression in atherosclerotic lesions.

Authors:  Mikko O Hiltunen; Mikko P Turunen; Tomi P Häkkinen; Juha Rutanen; Maria Hedman; Kimmo Mäkinen; Anna-Mari Turunen; Katriina Aalto-Setälä; Seppo Ylä-Herttuala
Journal:  Vasc Med       Date:  2002-02       Impact factor: 3.239

8.  Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution.

Authors:  Hongcang Gu; Christoph Bock; Tarjei S Mikkelsen; Natalie Jäger; Zachary D Smith; Eleni Tomazou; Andreas Gnirke; Eric S Lander; Alexander Meissner
Journal:  Nat Methods       Date:  2010-01-10       Impact factor: 28.547

9.  DNA methylation profiling of human chromosomes 6, 20 and 22.

Authors:  Florian Eckhardt; Joern Lewin; Rene Cortese; Vardhman K Rakyan; John Attwood; Matthias Burger; John Burton; Tony V Cox; Rob Davies; Thomas A Down; Carolina Haefliger; Roger Horton; Kevin Howe; David K Jackson; Jan Kunde; Christoph Koenig; Jennifer Liddle; David Niblett; Thomas Otto; Roger Pettett; Stefanie Seemann; Christian Thompson; Tony West; Jane Rogers; Alex Olek; Kurt Berlin; Stephan Beck
Journal:  Nat Genet       Date:  2006-10-29       Impact factor: 38.330

10.  On the presence and role of human gene-body DNA methylation.

Authors:  Daudi Jjingo; Andrew B Conley; Soojin V Yi; Victoria V Lunyak; I King Jordan
Journal:  Oncotarget       Date:  2012-04
View more
  115 in total

1.  Epigenetic silencing of Kruppel like factor-3 increases expression of pro-metastatic miR-182.

Authors:  Mohit Sachdeva; Rebecca D Dodd; Zhiqing Huang; Carole Grenier; Yan Ma; Dina C Lev; Diana M Cardona; Susan K Murphy; David G Kirsch
Journal:  Cancer Lett       Date:  2015-08-24       Impact factor: 8.679

Review 2.  Endothelial epigenetics in biomechanical stress: disturbed flow-mediated epigenomic plasticity in vivo and in vitro.

Authors:  Yi-Zhou Jiang; Elisabetta Manduchi; Juan M Jiménez; Peter F Davies
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

3.  AMPK promotes mitochondrial biogenesis and function by phosphorylating the epigenetic factors DNMT1, RBBP7, and HAT1.

Authors:  Traci L Marin; Brendan Gongol; Fan Zhang; Marcy Martin; David A Johnson; Han Xiao; Yinsheng Wang; Shankar Subramaniam; Shu Chien; John Y-J Shyy
Journal:  Sci Signal       Date:  2017-01-31       Impact factor: 8.192

4.  Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction.

Authors:  Aurelia De Pauw; Emilie Andre; Belaid Sekkali; Caroline Bouzin; Hrag Esfahani; Nicolas Barbier; Axelle Loriot; Charles De Smet; Laetitia Vanhoutte; Stéphane Moniotte; Bernhard Gerber; Vittoria di Mauro; Daniele Catalucci; Olivier Feron; Denise Hilfiker-Kleiner; Jean-Luc Balligand
Journal:  JCI Insight       Date:  2017-06-15

Review 5.  Coordination of Cellular Localization-Dependent Effects of Sumoylation in Regulating Cardiovascular and Neurological Diseases.

Authors:  Jun-Ichi Abe; Uday G Sandhu; Nguyet Minh Hoang; Manoj Thangam; Raymundo A Quintana-Quezada; Keigi Fujiwara; Nhat Tu Le
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 6.  Connecting the Dots Between Fatty Acids, Mitochondrial Function, and DNA Methylation in Atherosclerosis.

Authors:  Silvio Zaina; Gertrud Lund
Journal:  Curr Atheroscler Rep       Date:  2017-09       Impact factor: 5.113

7.  Oxidized low-density lipoprotein inhibits THP-1-derived macrophage autophagy via TET2 down-regulation.

Authors:  Guohua Li; Juan Peng; Yanhui Liu; Xiaohong Li; Qin Yang; Yongqing Li; Zhihan Tang; Zuo Wang; Zhisheng Jiang; Dangheng Wei
Journal:  Lipids       Date:  2014-12-14       Impact factor: 1.880

Review 8.  Targeting Mechanosensitive Transcription Factors in Atherosclerosis.

Authors:  Niu Niu; Suowen Xu; Yanni Xu; Peter J Little; Zheng-Gen Jin
Journal:  Trends Pharmacol Sci       Date:  2019-02-28       Impact factor: 14.819

9.  Shear stress makes its mark on the endothelial genome.

Authors:  Jovana Serbanovic-Canic; Celine Souilhol; Paul C Evans
Journal:  Cardiovasc Res       Date:  2019-08-01       Impact factor: 10.787

Review 10.  Atherosclerosis Is an Epigenetic Disease.

Authors:  Suowen Xu; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Trends Endocrinol Metab       Date:  2018-05-10       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.